Inventor

POSSEMATO ANTHONY

US16 patents

⚠️ This page may combine multiple inventors who share the name “POSSEMATO ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELL SIGNALING TECHNOLOGY INC

10 patents

US7700339B2Apr 20, 2010

Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer

CELL SIGNALING TECHNOLOGY INC0 citations62

US9988688B2Jun 5, 2018

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

CELL SIGNALING TECHNOLOGY INC1 citations62

US9523130B2Dec 20, 2016

Methods of treating non-small cell lung carcinoma (NSCLC)

CELL SIGNALING TECHNOLOGY INC1 citations62

US10870892B2Dec 22, 2020

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

CELL SIGNALING TECHNOLOGY INC0 citations51

US7977462B2Jul 12, 2011

Tyrosine phosphorylation sites

CELL SIGNALING TECHNOLOGY INC1 citations47

RIKOVA KLARISA

5 patents

US8481279B2Jul 9, 2013

Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase

RIKOVA KLARISA6 citations83

US8232060B2Jul 31, 2012

Gene defects and mutant ALK kinase in human solid tumors

RIKOVA KLARISA6 citations82

US8288102B2Oct 16, 2012

Gene defects and mutant ALK kinase in human solid tumors

RIKOVA KLARISA5 citations72

US8168383B2May 1, 2012

Gene defects and mutant ALK kinase in human solid tumors

RIKOVA KLARISA5 citations72

US8486645B2Jul 16, 2013

Gene defects and mutant ALK kinase in human solid tumors

RIKOVA KLARISA2 citations61

GUO AILAN

1 patent

US10889818B2Jan 12, 2021

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

GUO AILAN0 citations55